Dianthus Therapeutics (DNTH) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

DNTH is expected to report earnings to fall 19.58% to -303 cents per share on September 18

Dianthus Therapeutics DNTH Stock Earnings Reports

Q2'23

Est.

$-3.04

Q3'23

Missed

by $3.22

Q1'23

Missed

by $0.07

Q4'22

Missed

by $0.02

Q3'22

Beat

by $0.02

The last earnings report on November 09 showed earnings per share of -377 cents, missing the estimate of -56 cents. With 151.28K shares outstanding, the current market capitalization sits at 799.61M.

View a ticker or compare two or three

Compare

DNTH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DNTH
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DNTH (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7 Times Square

Phone

+1 929 999-4055

Employees

Web

https://www.dianthustx.com